Connect to other sites within the UBM Medica Network
Molecular Markers Help Stratify Risks in MI Patients
Dyslipidemia, insulinemia, and glycemia are among the most significant insulin resistance risk factors in the early recovery phases of myocardial infarction.
Inflammation Links MIs with Atrial Fibrillation
Myocardial infarction joins the list of cardiovascular disorders associated with atrial fibrillation, and premature atrial contraction proves a variable that can assess that risk.
Another CAD Marker: Red Cell Distribution Width
A numerical measure of erythrocyte heterogeneity, RDW proves a reliable predictor of mortality in coronary artery disease patients due for stenting, and perhaps of cardiovascular disease burden in general.
Heart-healthy Diets, Plus Nuts, Reduce the Risk of Death
Post-myocardial infarction, people whose eating habits resembled the Mediterranean diet were less likely to die of any cause, in data from large longitudinal studies.
Diagnosing CAD: What Value for MR Coronary Angiography?
A noninvasive method of looking for coronary artery disease proves not good enough. Other researchers assess the true costs of cardiovascular imaging in more than economic terms.
CETP Inhibition Raises HDL and Postprandial Insulin Concentration
Elevating HDL by inhibiting a protein that transfers molecules between the lipids seems to influence glucose metabolism and may even increase longevity.
NSAIDs and Cardiovascular Risk: Which, and When?
A meta-analysis finds that naproxen may be the best NSAID for arthritis pain relief. But a cohort study strongly suggests avoiding NSAIDs altogether after myocardial infarction.